Skip to content

To study the effect of paste (dimad) of compound unani formulation in Melasma

Evaluation of therapeutic effects of Dimad (paste) of Filfil siyah (Piper nigrum L.) and Suhaga (Borax) in the management of Kalaf (Melasma); An open-label, parallel group, randomized, standard control study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082089
Enrollment
58
Registered
2025-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L819- Disorder of pigmentation, unspecified

Interventions

Intervention1: hskd: sdhmd Intervention2: Dimad (Paste) Local Application: The formulation consists of two herbal drugs namely Filfil Siyah (Piper Nigrum L.) and Suhaga (Borax). 1 FTU(finger tip unit)

Sponsors

Central Council for Research in Unani Medicine CCRUM New Delhi India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of age between 18-60 years. 2.Patients irrespective of gender. 3.Clinically diagnosed patients of melasma of both epidermal and dermal types. 4.Patients who willingly provide written informed consent and are capable of attending follow up appointments.

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women. 2.Patients on OCP s and hormonal IUDs. 3.Known cases of malignancies, systemic illnesses like cardiovascular disorders, chronic kidney disease, chronic liver disease and thyroid disease 4.Patients who refuse to give the written consent for the study and unwillingness to come for regular follow up as described in the study plan. 5.Subjects with local inflammatory skin disorders and active herpes infection

Design outcomes

Primary

MeasureTime frame
1) Change from baseline to day 41st in the mMASI scale (Modified Melasma Area and Severity Index)Timepoint: 40 days

Secondary

MeasureTime frame
1) MELASQOL 2) Change from baseline to day 41st in Photographic images of affected areaTimepoint: 1) 0 day, 10th day, 20th day, 30th day and 41st day 2) 40days

Countries

India

Contacts

Public ContactMehwish Ayoub

Regional Research Institute of Unani Medicine University of Kashmir Srinagar

drsheerazmd@gmail.com9797750472

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026